Published: August 26, 2015. Therese Dodd, RN, MBA, CPHQ, Quality Improvement Director at Sarah Cannon Blood and Marrow Transplant Program, shared her experience and success with organizational structure and charts.

Published: October 14, 2015. Lisa Cantwell, MHA, CPHQ, Quality Manager from St. David's South Austin Medical Center, and Diane Fournier, PhD, from Héma-Québec, described methods for assessing organizational performance and compliance with accreditation and quality requirements. 

Published: January 13, 2016. Dr. Robert Rifkin, Member, Cellular Therapeutics Department, gave an overview of Quality Management principles and elements. 

Published: February 10, 2016. The presenters gave an overview of how their organizations set up a Quality Management program and maintained a quality culture in the organization.

The seventh edition of the FACT-JACIE Hematopoietic Cellular Therapy Standards, effective May 30, 2018, requires full implementation of ISBT 128 labeling and coding. Dr. Phyllis I. Warkentin discussed common questions about ISBT 128 terminology, product codes, FACT Standards, and regulatory requirements in this 90-minute webinar.

Marcelo Fernández-Viña, PhD, HLA Consultant in the HLA Laboratory at Stanford Medicine Blood and Marrow Transplant Program, gave an overview of histocompatibility testing in HCT and the impact on clinical outcomes driving test selections.

Cellular therapy, and healthcare in general, are at the forefront of several initiatives to increase quality in patient care. The blood and marrow transplant field has been a leader in voluntarily improving quality, and new FACT accreditation requirements have been implemented to facilitate real results that directly impact patients.

This bundle of the QM Series consists of sessions related to outcome analysis, specifically related to cellular therapy programs and cord blood banks. Advance registration and post-webinar recordings of the following webinars are included at a discounted rate: 

1. Benchmarking One-Year Survival (November 30, 2016)
2. Completing FACT-Required Outcome Analyses (January 11, 2017)
3. Making Outcome Analysis Work for You (January 25, 2017)
4. Improving Our Clinical Outcomes Virtual Roundtable (February 8, 2017) 

Published February 2016. This QM Series consists of sessions about creating a culture of quality and accountability within the organization, specifically related to cellular therapy programs and cord blood banks. 

The following webinars are included in the bundled series: 

1. Organizational Structure and Charts (August 26, 2015)
2. Organizational Self-Assessments (October 14, 2015)
3. Quality Management Overview (January 13, 2016)
4. Quality Organization Virtual Roundtable (February 10, 2016)

This QM Series bundle consists of document control sessions specifically related to cellular therapy programs and cord blood banks. Handouts and post-webinar recordings of the following webinars are included at this discounted rate: 

1. The Document Control Process From Start to Finish (and Back Again!) (September 13, 2017)
2. Staff Involvement in Document Control: Where do YOU fit in? (January 10, 2018)
3. The Digital Age: Controlling Documents within an Electronic System (January 24, 2018)
4. Virtual Roundtable: Control of Different Types of Documents (August 29, 2018)